Skip to main content
. 2020 Jan 24;69(3):90–94. doi: 10.15585/mmwr.mm6903e2

TABLE. Demographic and product use characteristics among hospitalized patients with e-cigarette, or vaping, product use–associated lung injury (EVALI) reported to CDC — United States, August 2019–January 2020*.

Characteristic (no. with available information) No. (%)
(N = 2,668)
Sex (2,606)
Male
1,731 (66)
Female
875 (34)
Median age, yrs (range)
24 (13–85)
Age group (yrs) (2,619)
13–17
404 (15)
18–24
979 (37)
25–34
631 (24)
35–44
335 (13)
45–64
223 (9)
≥65
47 (2)
Race/Ethnicity§ (1,856)
White
1,360 (73)
Black
64 (3)
American Indian/Alaska Native
12 (1)
Asian/Native Hawaiian/Other Pacific Islander
38 (2)
Other
97 (5)
Hispanic
285 (15)
Case status (2,668)
Confirmed
1,401 (53)
Probable
1,267 (47)
Substances used in e-cigarette, or vaping, products (2,022) ¶,**
Any THC-containing product
1,650 (82)
Any nicotine-containing product
1,162 (57)
Both THC- and nicotine-containing product use
834 (41)
Exclusive THC-containing product use
669 (33)
Exclusive nicotine-containing product use
274 (14)
No THC- or nicotine-containing product use reported 44 (2)

Abbreviation: THC = tetrahydrocannabinol.

* For cases reported to CDC as of January 14, 2020.

Percentages might not sum to 100% because of rounding.

§ These were mutually exclusive groups. Whites, blacks, American Indians/Alaska Natives, Asians/Native Hawaiians/Other Pacific Islanders, and Others were non-Hispanic. Hispanic persons could be of any race.

Limited to persons who reported vaping or dabbing at least one substance in the past 3 months.

** In the 3 months preceding symptom onset.